FDUS Stock Analysis: Fidus Investment | NASDAQ
Asset Management | NASDAQ, USA | Market Cap: 773m USD | 12M Return: 2.8% | Charts, Fundamentals & Technical Analysis
Avg Turnover: 7.11M
EPS Trend: -67.8%
Qual. Beats: 2
Rev. Trend: 78.8%
Qual. Beats: 0
Warnings
No concerns identified
Tailwinds
Seasonality 10.5 years of data
How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, >40 gets interesting and >55 is strong.
Fidus Investment Corporation (NASDAQ: FDUS) is a Business Development Company (BDC) that provides financing solutions to lower middle market businesses in the United States. As a BDC, the company operates under the Investment Company Act of 1940 and is structured to channel capital to private, small and mid-sized enterprises that often have limited access to traditional bank financing.
Fidus focuses on leveraged buyouts, refinancings, recapitalizations, strategic acquisitions, growth capital, and business expansion transactions. It does not invest in turnarounds or distressed situations. Its debt instruments include subordinated and second lien loans, senior secured and unitranche debt, junior secured loans, and senior subordinated notes, while its equity-oriented investments consist of preferred equity and warrants. The company typically invests between $5 million and $30 million per transaction, with debt investments generally ranging from $5 million to $15 million.
The companys investment focus spans a diverse range of industries, including aerospace and defense, business services, consumer products and retail, food and beverage, healthcare, industrial products and services, information technology, niche manufacturing, transportation and logistics, and value-added distribution. Fidus generally targets US-based companies with annual revenues between $10 million and $150 million and annual EBITDA between $5 million and $30 million.
In conjunction with its financing activities, Fidus typically seeks to acquire minority equity stakes and board observation rights, allowing it to maintain oversight while supporting portfolio company growth.
- Net interest income expands as floating-rate debt assets reprice higher
- Non-accruals and credit losses rise on lower middle market borrower stress
- Deployment pace in unitranche loans drives NAV and dividend coverage
| Net Income: 82.6m TTM > 0 and > 6% of Revenue |
| FCF/TA: -0.06 > 0.02 and ΔFCF/TA -6.35 > 1.0 |
| NWC/Revenue: 12.64% < 20% (prev 33.57%; Δ -20.93% < -1%) |
| CFO/TA -0.06 > 3% & CFO -83.8m > Net Income 82.6m |
| Net Debt (506.5m) to EBITDA (100.0m): 5.07 < 3 |
| Current Ratio: 1.51 > 1.5 & < 3 |
| Outstanding Shares: last quarter (38.0m) vs 12m ago 11.38% < -2% |
| Gross Margin: 74.35% > 18% (prev 80.12%; Δ -5.77% > 0.5%) |
| Asset Turnover: 9.92% > 50% (prev 9.32%; Δ 0.61% > 0%) |
| Interest Coverage Ratio: 2.99 > 6 (EBIT TTM 97.1m / Interest Expense TTM 32.4m) |
| A: 0.01 (Total Current Assets 49.7m - Total Current Liabilities 32.8m) / Total Assets 1.44b |
| B: 0.07 (Retained Earnings 100.6m / Total Assets 1.44b) |
| C: 0.07 (EBIT TTM 97.1m / Avg Total Assets 1.34b) |
| D: 1.06 (Book Value of Equity 742.0m / Total Liabilities 702.2m) |
| Altman-Z'' = 1.90 = BBB |
As of July 27, 2026, the stock is trading at USD 19.41 with a total of 171,170 shares traded. Over the past week, the price has changed by -4.67%, over one month by +3.35%, over three months by +9.18% and over the past year by +2.84%.
Current recommended Stop Loss: 18.70 (which is 3.7% or 1.5 ATR below the current price).
Fidus Investment has received a consensus analysts rating of 4.25. Therefore, it is recommended to buy FDUS.
- StrongBuy: 2
- Buy: 1
- Hold: 1
- Sell: 0
- StrongSell: 0
| Analysts Target Price | 21.5 | 10.8% |
P/E Trailing = 9.0089
P/E Forward = 10.395
P/S = 4.63
P/B = 1.0419
P/EG = 3.5213
Revenue TTM = 133.3m USD
EBIT TTM = 97.1m USD
EBITDA TTM = 100.0m USD
Long Term Debt = unknown (none)
Short Term Debt = unknown (none)
Debt = 668.1m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 506.5m USD (calculated: Debt 668.1m - CCE 161.6m)
Enterprise Value = 1.28b USD (772.8m + Debt 668.1m - CCE 161.6m)
Interest Coverage Ratio = 2.99 (Ebit TTM 97.1m / Interest Expense TTM 32.4m)
EV/FCF = -15.26x (Enterprise Value 1.28b / FCF TTM -83.8m)
FCF Yield = -6.55% (FCF TTM -83.8m / Enterprise Value 1.28b)
FCF Margin = -62.89% (FCF TTM -83.8m / Revenue TTM 133.3m)
Net Margin = 62.00% (Net Income TTM 82.6m / Revenue TTM 133.3m)
Gross Margin = 74.35% ((Revenue TTM 133.3m - Cost of Revenue TTM 34.2m) / Revenue TTM)
Gross Margin QoQ = 67.40% (prev 73.45%)
Tobins Q-Ratio = 0.89 (Enterprise Value 1.28b / Total Assets 1.44b)
Interest Expense / Debt = 4.85% (Interest Expense 32.4m / Debt 668.1m)
Taxrate = 5.22% (4.55m / 87.2m)
NOPAT = 92.0m (EBIT 97.1m * (1 - 5.22%))
Current Ratio = 1.51 (Total Current Assets 49.7m / Total Current Liabilities 32.8m)
Debt / Equity = 0.90 (Debt 668.1m / totalStockholderEquity, last quarter 742.0m)
Debt / EBITDA = 5.07 (Net Debt 506.5m / EBITDA 100.0m)
Debt / FCF = -6.04 (negative FCF - burning cash) (Net Debt 506.5m / FCF TTM -83.8m)
Total Stockholder Equity = 721.8m (last 4 quarters mean from totalStockholderEquity)
RoA = 6.15% (Net Income 82.6m / Total Assets 1.44b)
RoE = 11.45% (Net Income TTM 82.6m / Total Stockholder Equity 721.8m)
RoCE = 6.88% (EBIT 97.1m / Capital Employed (Total Assets 1.44b - Current Liab 32.8m))
RoIC = 6.55% (NOPAT 92.0m / Invested Capital 1.40b)
WACC = 6.50% (E(772.8m)/V(1.44b) * Re(8.14%) + D(668.1m)/V(1.44b) * Rd(4.85%) * (1-Tc(0.05)))
Discount Rate = 8.14% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: 94.00 | Cagr: 17.58%
[DCF] Fair Price = unknown (Cash Flow -83.8m)
EPS Correlation: -67.79 | EPS CAGR: -4.61% | SUE: 4.0 | # QB: 2
Revenue Correlation: 78.80 | Revenue CAGR: 12.65% | SUE: -0.60 | # QB: 0
EPS current Quarter (2026-06-30): EPS=0.50 | Chg30d=+0.40% | Revisions=+57% | Analysts=5
EPS next Quarter (2026-09-30): EPS=0.51 | Chg30d=+0.80% | Revisions=+29% | Analysts=5
EPS current Year (2026-12-31): EPS=2.12 | Chg30d=+6.21% | Revisions=+62% | GrowthEPS=-0.5% | GrowthRev=+13.4%
EPS next Year (2027-12-31): EPS=1.95 | Chg30d=+0.64% | Revisions=-25% | GrowthEPS=-7.9% | GrowthRev=+0.8%
[Analyst] Revisions Ratio: +59% (up=12, down=2)